# Para-aortic lymphocele treated with an injection of somatostatine analog (lanreotide).

> PubMed lists PMID 18684551 in European journal of obstetrics, gynecology, and reproductive biology as Case Reports, Letter, with publication-date metadata of 2008-08-05 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-18684551-lanreotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2016-11-24
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-18684551-lanreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-18684551-lanreotide-v1.json
- Content SHA-256: `a4942b3c06a35fd6edbe7cb1c59b7235e2be39aab94e701a2c1a13ed4243704b`

## Claims and source pins

### Headline

Para-aortic lymphocele treated with an injection of somatostatine analog (lanreotide). ([`pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1`](#source-pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1))

### Summary

PubMed lists PMID 18684551 in European journal of obstetrics, gynecology, and reproductive biology as Case Reports, Letter, with publication-date metadata of 2008-08-05 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1`](#source-pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1))

### Paragraph 1

PubMed lists PMID 18684551 in European journal of obstetrics, gynecology, and reproductive biology as Case Reports, Letter, with publication-date metadata of 2008-08-05 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1`](#source-pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1`](#source-pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1))

## Sources

<a id="source-pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1"></a>
- **Para-aortic lymphocele treated with an injection of somatostatine analog (lanreotide). · retained source version 1:2016-11-24:current:f00668d1cea11b16c76c7065f9b57f9e57a3ab91ba9651eda1d2ff6fa6219be6** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/18684551/) (`pubmed-observation-pmid-18684551-2016-11-24-f00668d1cea1`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Para-aortic lymphocele treated with an injection of somatostatine analog (lanreotide)." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-18684551-lanreotide-v1.json SHA-256: a4942b3c06a35fd6edbe7cb1c59b7235e2be39aab94e701a2c1a13ed4243704b.